$PFE Company News Inversions are not such a sweet deal

New Post Public Reply Private Reply Replies (0) Message Board

Aug 26, 2014 at 11:49 AM

$PFE Company News

Inversions are not such a sweet deal for fund investors 1:47 p.m. Aug. 18, 2014 - Chuck Jaffe
Tax inversions can be bad for shareholders — and for America 2:31 p.m. Aug. 17, 2014 - Chuck Jaffe
Investors sent on a wild ride by hostile deals 12:56 p.m. Aug. 15, 2014 - David Weidner
Timing this market is guaranteed to make you a loser 1:02 p.m. Aug. 8, 2014 - Mark Hulbert
Tax inversions help, not hurt, the economy 7:20 a.m. Aug. 8, 2014 - Diana Furchtgott-Roth
Mega caps with mega recommendations 7:54 a.m. Aug. 6, 2014 - Mark Hulbert
Zoetis narrows full-year earnings guidance 8:12 a.m. Aug. 5, 2014 - MarketWatch.com
‘Inversion’ payoff for shareholders is muted at tax time 11:42 a.m. Aug. 3, 2014 - Laura Saunders
5 ways to profit from sex (without having it) 8:45 a.m. Aug. 3, 2014 - Charles Passy
AstraZeneca raises earnings view as sales rise 3:01 a.m. July 31, 2014 - MarketWatch.com
Pfizer to buy Baxter’s vaccines for $635 million 8:32 a.m. July 30, 2014 - Anna Prior
U.S. stocks end choppy trade lower 4:16 p.m. July 29, 2014 - Carla Mozee
Herbalife sinks on disappointing results; Darden gains 3:16 p.m. July 29, 2014 - Angela Johnson
Newscast: Investors await Fed meeting 10:01 a.m. July 29, 2014 - MarketWatch
Newscast: Wall Street may gain ground 7:35 a.m. July 29, 2014 - MarketWatch
Pfizer shares rise 1.3% in premarket trade after Q2 results 7:25 a.m. July 29, 2014 - Tomi Kilgore
Pfizer profit rises above estimates 7:24 a.m. July 29, 2014 - MarketWatch.com
The market in a minute: What will GDP mean for the market? 12:47 p.m. July 28, 2014 - The Trading Deck
Correction: Blog points out Valeant's diverse portfolio is key to its success 1:53 p.m. July 21, 2014 - blogs.marketwatch.com
Two rules of thumb for dumping your financial adviser 2:36 p.m. July 18, 2014 - Mark Hulbert

Pfizer, Merck Team Up on Cancer Study 8:42 a.m. Today - The Wall Street Journal Interactive Edition
Pfizer and Merck team up in cancer study 8:18 a.m. Today - Seeking Alpha
ViiV Healthcare's Single-Pill HIV Drug Triumeq Cleared by FDA - Analyst Blog 4:30 p.m. Aug. 25, 2014 - Zacks.com
Jackson Hole And Complacency 12:18 a.m. Aug. 24, 2014 - Seeking Alpha
Despite Gains, European Pharma Looks Sickly 1:41 a.m. Aug. 23, 2014 - Barrons.com
Durata exercises milestone payment deferral right 8:02 p.m. Aug. 22, 2014 - Seeking Alpha
Bristol-Myers/Pfizer's Eliquis Gets Yet Another FDA Nod - Analyst Blog 5:55 p.m. Aug. 22, 2014 - Zacks.com
ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection 3:46 p.m. Aug. 22, 2014 - CNW Group
FDA approves single-pill regimen HIV med 3:32 p.m. Aug. 22, 2014 - Seeking Alpha
Tonix Could Match Pfizer's Biggest Drug's Best Market 9:43 a.m. Aug. 22, 2014 - Seeking Alpha
Pfizer Inc. (PFE): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Aug. 22, 2014 - Zacks.com
Sweet Lawsuit Home, Alabama 7:35 p.m. Aug. 21, 2014 - The Wall Street Journal Interactive Edition
Astellas-Basilea's Isavuconazole Accepted for EU Review - Analyst Blog 5:30 p.m. Aug. 21, 2014 - Zacks.com
FDA approves Eliquis label expansion 3:51 p.m. Aug. 21, 2014 - Seeking Alpha
Puma Biotechnology: Who Are They? What Happened? And, Where Are They Going? 3:50 p.m. Aug. 21, 2014 - Seeking Alpha
ELIQUIS Approved for Deep Vein Thrombosis and Pulmonary Embolisms 2:14 p.m. Aug. 21, 2014 - 247WallSt.com
Contract Researcher Parexel Sees Growth In Biotech 2:00 p.m. Aug. 21, 2014 - Investors Business Daily
Pfizer may make another run at AstraZeneca by year end 11:47 a.m. Aug. 21, 2014 - Seeking Alpha
Illumina Forms Partnerships With Big Pharma Firms 11:03 a.m. Aug. 21, 2014 - Investors Business Daily
Why AstraZeneca (AZN) Stock Is Higher Today 9:35 a.m. Aug. 21, 2014 - TheStreet.com

Pfizer And Merck To Collaborate On Study Evaluating Novel Anti-Cancer Combination Regimen 8:01 a.m. Today - BusinessWire - BZX
Aortic Valve Stenosis Global Clinical Trials Review, H2, 2014 2:44 p.m. Aug. 25, 2014 - PR Newswire - PRF
Arteriosclerosis Global Clinical Trials Review, H2, 2014 2:41 p.m. Aug. 25, 2014 - PR Newswire - PRF
Social Anxiety Disorders (SAD) Global Clinical Trials Review, H2, 2014 2:38 p.m. Aug. 25, 2014 - PR Newswire - PRF
Multimedia assets now available: ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection 9:00 a.m. Aug. 25, 2014 - PR Newswire - PRF
ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection 3:46 p.m. Aug. 22, 2014 - PR Newswire - PRF
Palbociclib Expanded Access Program Now Open To Eligible U.S. Patients With HR+, HER2- Advanced Breast Cancer 8:00 a.m. Aug. 21, 2014 - BusinessWire - BZX
Expanding IBD Research Through Collaboration 9:00 a.m. Aug. 20, 2014 - PR Newswire - PRF
Technical Updates, Drug Recommendations, and Upcoming Events - Research Reports on Gilead, Pfizer, AbbVie, Express Scripts and Humana 9:20 a.m. Aug. 19, 2014 - PR Newswire - PRF
Premier Biotechnology & Anti-CTLA4 8:02 a.m. Aug. 18, 2014 - ACCESSWIRE
Pfizer Announces Submission of Palbociclib New Drug Application to the FDA 8:00 a.m. Aug. 18, 2014 - BusinessWire - BZX
Pfizer Announces FDA Acceptance Of And Priority Review Designation For Biologics License Application For Investigational Meningococcal B Vaccine 5:01 p.m. Aug. 14, 2014 - BusinessWire - BZX
Advisory Committee on Immunization Practices Votes to Recommend Pfizer’s Prevnar 13® Vaccine in Adults Aged 65 Years and Older 5:43 p.m. Aug. 13, 2014 - BusinessWire - BZX
Pfizer Reports Top-line Results from Postherpetic Neuralgia and Painful Diabetic PeripheralNeuropathy Lyrica® Studies Conducted in China 5:03 p.m. Aug. 12, 2014 - BusinessWire - BZX
Study Links Viagra(R) to Skin Cancer 11:20 a.m. Aug. 12, 2014 - Marketwire
Entia Biosciences' Supplements Could Prevent Dementia 9:55 a.m. Aug. 12, 2014 - ACCESSWIRE
Pharma Equities Coverage -- Pfizer, BioDelivery Sciences Intl., The Medicines, Questcor Pharma, and Nektar Therapeutics 9:00 a.m. Aug. 12, 2014 - PR Newswire - PRF
23andMe Announces Agreement with Pfizer Inc. to Research Genetics of Ulcerative Colitis and Crohn's Disease 9:00 a.m. Aug. 12, 2014 - PR Newswire - PRF
Renal Pain Global Clinical Trials Review, H2, 2014 4:37 p.m. Aug. 11, 2014 - PR Newswire - PRF
Positive Opinion on the Drug, Acquisition, Orphan Drug Designation, Analysis Results, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Express Scripts and Tenet Health 9:10 a.m. Aug. 8, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

EFSI Shareholders on Alert Amid M&A Deal Scrutiny

Eagle Financial Services Under the Microscope A buzz is picking up in the world of mergers and acquisitions, and this time, it's Eagle Financial Services, Inc. (NASDAQ: EFSI) caught in the crosshairs. What's the chatter all about? Well, it looks like Juan Monteverde and his crew over at Monteverde & Associates PC have set their sights on Eagle's proposed sale to John...

Midlife ADHD in Women: New Challenges and Solutions

ADHD Evolution in Women's Midlife They say change is the only constant, and boy, does that ring true for women navigating the turbulent seas of ADHD as they hit 40 and beyond. According to Germaine Swanson, the ADHD landscape changes dramatically in midlife, especially for women. We're talking about a mix of hormonal shifts, increasing life demands, and changes in brain...

South Florida Donor Network Honors 52 Heroic Donors

A Heartfelt Tribute to Lifesavers You ever been to a gathering that reminds you how deeply human connections run? That's what happened at The Diplomat Beach Resort in Hollywood. South Florida Donor Network (SFDN) pulled together a ceremony honoring 52 donor heroes whose legacies beat strong through the recipients living thanks to their gifts. An Event Worth Attending...

Tampa General’s Innovation Excellence Earns No. 20 Spot

A Bold Leap into Innovation at Tampa General There's a heck of a lot going on down in Tampa that's worth more than just a golf clap. Tampa General Hospital (TGH) just snagged the 20th spot on Fast Company's Best Workplaces for Innovators list, and let me tell you, that’s no small feat amidst the heavy hitters in verticals like biotech and consumer goods. It takes guts...

Push Notification Security Transforms Healthcare IT Support

Cutting the Fat on IT Help Desk Bottlenecks Healthcare IT teams are fighting an uphill battle with password resets, a mundane task consuming up to half of all help desk calls. It's like trying to stop a leaking dam with duct tape. For health systems, these calls aren't just a minor annoyance—they're a full-fledged budget hog. Try telling a CIO that an agent-friendly...

Give Lively & Change Simplify CA Nonprofit Compliance

A Fresh Wind Blowing for California Nonprofits So, here's a twist in the nonprofit world that's stirring the pot just right. Give Lively and Change have partnered up to tackle the thorny issue of regulatory compliance in California. It's a big win for the nonprofits looking to keep fundraising through Give Lively without getting tangled in the bureaucratic web spun up by...

Health Net's $2M Boost for Stanislaus Affordable Housing

Joining the Fight Against California’s Housing Crisis Well, I'll be the first to say it's a breath of fresh air when a healthcare beast like Health Net starts investing in something as critical as affordable housing. This is no drop in the bucket—two million dollars is quite the commitment to fix some of the mess that’s been brewing in Stanislaus County, California....

Cap Juluca: Caribbean Luxury Redefined on Maundays Bay

The Tranquil Call of Maundays Bay Find me dipping my toes in the sands of Maundays Bay come October 10, 2026, and you'll understand why this slice of Anguilla stakes its claim to being the best beach on the globe. Cap Juluca, that crown jewel of Caribbean luxury, swings open its doors once more, promising indulgence framed by turquoise waters and the soft whisper of white...

Monib Zirvi's Dermatology Excellence Honored in 2026

Trailblazer in Dermatology Recognized Again Fancy yourself a star in dermatology? Well, take notes from Dr. Monib A. Zirvi. The guy just got his due recognition from Marquis Who's Who for his sizable contributions to dermatology and research. For someone who's been at this game for over two decades, Zirvi doesn't just glide by on old merits. He's the real deal, and his...

From Kitchen Experiment to U.S. Debut Here's a story that barely fits the tight mold of your typical business textbook. Hair Syrup, born from the brain of a university student tinkering at her kitchen table, is about to make waves across the pond. Lucie Macleod did what many dream of—she took a DIY hair oil project and spun it into a multimillion-dollar brand, now set...